Clinical Trials
10
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Exoskeleton Training at Home to Assist Participants With Spinal Cord Injuries to Perform Ambulatory Functions.
- Conditions
- Spinal Cord Injury
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- ABLE Human Motion S.L.
- Target Recruit Count
- 10
- Registration Number
- NCT07062575
- Locations
- 🇳🇱
Sint Maartenskliniek, Hengstdal, Ubbergen, Netherlands
Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting
- Conditions
- Acquired Brain Injury (Including Stroke)
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- ABLE Human Motion S.L.
- Target Recruit Count
- 15
- Registration Number
- NCT07050875
- Locations
- 🇪🇸
Cefine Neurología (CEFINE), Culleredo, A Coruña, Spain
🇪🇸Fundación Step by Step, L'Hospitalet de Llobregat, Barcelona, Spain
🇪🇸Centro Europeo de Neurociencias (CEN), Madrid, Spain
A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the Spanish Healthcare System
- Conditions
- Spinal Cord Injury
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- ABLE Human Motion S.L.
- Target Recruit Count
- 80
- Registration Number
- NCT07036107
- Locations
- 🇪🇸
Hospital Nacional de Parapléjicos, Toledo, Castilla La Mancha, Spain
🇪🇸Hospital Universitario de Vall d'Hebron, Barcelona, Catalunya, Spain
Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- ABLE Human Motion S.L.
- Target Recruit Count
- 20
- Registration Number
- NCT06921551
- Locations
- 🇪🇸
Fundación Esclerosis Múltiple Madrid (FEMM), Madrid, Spain
Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- ABLE Human Motion S.L.
- Target Recruit Count
- 33
- Registration Number
- NCT06261541
- Locations
- 🇪🇸
Fundación Esclerosis Múltiple Madrid (FEMM), Madrid, Spain
- Prev
- 1
- 2
- Next